Biotech

All Articles

AstraZeneca IL-33 medicine neglects to boost COPD breathing in ph. 2

.AstraZeneca managers mention they are "not concerned" that the failing of tozorakimab in a phase 2 ...

BMS vet answers Foghorn's ask for CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable management hirings, shootings and ...

Zenas, Bicara laid out to put forward $180M-plus in separate IPOs

.After exposing plannings to hit the U.S. social markets lower than a month ago, Zenas Biopharma and...

Psyence acquires fellow psilocybin biotech Clairvoyant

.Psyence Biomedical is actually paying $500,000 in portions to acquire fellow psilocybin-based biote...

FDA anxious Iterum's urinary system tract infection drug could possibly trigger antimicrobial protection

.5 months after accepting Electrical Therapeutics' Pivya as the 1st brand new treatment for uncompli...

Eli Lilly dives deeper into AI with $409M Genetic Surge deal

.Eli Lilly has actually vaulted into an AI-enabled medication breakthrough deal, partnering along wi...

After FDA rejection as well as layoffs, Lykos chief executive officer is leaving behind

.Lykos chief executive officer and creator Amy Emerson is actually stepping down, along with main op...

Novartis stirs up brand new phase of Voyager treaty with $15M capsid package

.Novartis levels a brand-new outpost in its own collaboration with Voyager Rehabs, paying $15 thousa...

Lilly blog posts extra positive records on its own weekly blood insulin possibility

.On the heels of an FDA being rejected for its main rivalrous Novo Nordisk, Eli Lilly is pulling ahe...

IN 8bio stops phase 2 test, gives up half of workforce

.Only a few months after application the initial person in a phase 2 trial for freshly detected glio...